Qube Research & Technologies (QRT)
ACOR

Qube Research & Technologies (QRT)’s Acorda Therapeutics ACOR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$13 – 4972
2024
Q1 		$13 Hold
1
– – ﹤0.01% 4288
2023
Q4 		$15 Hold
1
– – ﹤0.01% 4150
2023
Q3 		$15 Buy
+1
New +$15 ﹤0.01% 3904
2021
Q1 		– Sell
-328
Closed -$27K – 2547
2020
Q4 		$27K Buy
328
+56
+21% +$5.15K ﹤0.01% 1719
2020
Q3 		$17K Sell
272
-204
-43% -$15.4K ﹤0.01% 1586
2020
Q2 		$42K Buy
+476
New +$50.3K ﹤0.01% 1618
2020
Q1 		– Sell
-94
Closed -$23K – 1800
2019
Q4 		$23K Buy
+94
New +$23.7K ﹤0.01% 1496

Other funds holding ACOR

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ACOR Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Acorda Therapeutics (ACOR) in Q2 2024, closing a stake of 1 share — an estimated $13 sold.

Qube Research & Technologies (QRT) first reported a position in ACOR in Q4 2019 and held it in 7 quarters. The position peaked at $42K in Q2 2020. 2 funds tracked by Wall St. Rank hold ACOR as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Acorda Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1 Acorda Therapeutics share in Q2 2024, an estimated $13.
  • Qube Research & Technologies (QRT) first reported a position in Acorda Therapeutics in Q4 2019 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Acorda Therapeutics position peaked at $42K in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.